In the news
2020 in review: PBMs continue integration, face more regulatory challenges
January 11, 2021Spotlight on MMIT Solutions
Related news
In the news
May 29, 2022
Biosimilars Can Help Lower Patient Drug Costs When the Right Teams Come Together: Prime Therapeutics Executive
Managed Healthcare Executive
In the news
May 5, 2022
Prime Therapeutics buying Magellan Health’s pharma business for $1.35 billion
Minneapolis/St. Paul Business Journal